Weighted-Average Shares Outstanding (Diluted): The number of shares held by shareholders including insiders but not including a company's treasury shares assuming conversion of all convertible debt, securities, warrants and options, sourced from the company 10-K or 10-Q SEC reports.
Adaptive Biotechnologies Corporation (ADPT) had Weighted-Average Shares Outstanding (Diluted) of 147.10M for the most recently reported fiscal year, ending 2024-12-31.
| Income Statement Financials | |
$178.96M |
|
$-159.49M |
|
$72.08M |
|
$106.88M |
|
$341.51M |
|
$-162.55M |
|
$2.95M |
|
$-159.59M |
|
$-159.59M |
|
$-159.59M |
|
$-159.59M |
|
$-159.59M |
|
$-159.59M |
|
$-162.55M |
|
$-151.50M |
|
147.10M |
|
|
Weighted-Average Shares Outstanding (Diluted) |
147.10M |
$-1.08 |
|
$-1.08 |
|
| Balance Sheet Financials | |
$283.75M |
|
$48.62M |
|
$255.62M |
|
$539.38M |
|
$98.05M |
|
-- |
|
$238.84M |
|
$336.89M |
|
$202.49M |
|
$80.09M |
|
$202.49M |
|
147.77M |
|
| Cash Flow Statement Financials | |
$-95.21M |
|
$77.79M |
|
$0.24M |
|
$68.00M |
|
$50.82M |
|
$-17.18M |
|
$53.61M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.89 |
|
-- |
|
-- |
|
-- |
|
-- |
|
59.72% |
|
-90.83% |
|
-90.83% |
|
-84.66% |
|
-89.18% |
|
-89.12% |
|
$-98.88M |
|
-- |
|
-- |
|
-- |
|
0.33 |
|
8.54 |
|
4.29 |
|
85.11 |
|
-78.82% |
|
-199.27% |
|
-29.59% |
|
-78.82% |
|
$1.37 |
|
$-0.67 |
|
$-0.65 |
|